Clinical Trials
16
Active:0
Completed:16
Trial Phases
3 Phases
Phase 1:13
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
13 (81.3%)Phase 2
2 (12.5%)Phase 3
1 (6.3%)A Safety Study of PTI-125 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Alzheimer Disease, Early OnsetAlzheimer Disease
- Interventions
- Drug: 200 mg PTI-125Drug: 50 mg PTI-125Drug: 100 mg PTI-125
- First Posted Date
- 2018-12-21
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 24
- Registration Number
- NCT03784300
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
Phase 2
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Drug: PTI-125, 100 mg tablets
- First Posted Date
- 2018-11-21
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 13
- Registration Number
- NCT03748706
- Locations
- 🇺🇸
Insite Clinical Research, DeSoto, Texas, United States
🇺🇸Clinical Trials of Texas, San Antonio, Texas, United States
Nasal Human Abuse Potential of PTI-821
Phase 1
Completed
- Conditions
- Opioid Abuse Nondependent
- Interventions
- Other: PlaceboDrug: PTI-821 Non-manipulatedDrug: PTI-821 capsule Manipulated
- First Posted Date
- 2018-03-23
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 38
- Registration Number
- NCT03475862
- Locations
- 🇺🇸
PRA-EDS, Salt Lake City, Utah, United States
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 17
- Registration Number
- NCT02165930
- Locations
- 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 34
- Registration Number
- NCT02117583
- Locations
- 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found